By David,
Healthcare signatures carry more weight than most: a clinician's credentials are regulated representations, a misdirected reply-to can route patient communication wrong, and marketing's brand refresh has to coexist with medical-staff bylaws about how providers identify themselves. And all of it operates under the discipline HIPAA imposes on anything that touches email - because in a provider organization, email will sometimes contain PHI, whatever policy says about keeping it in the portal.
That last fact is the architectural crux of choosing signature tooling in healthcare, so let's start there.
The mail-path question is a HIPAA question
Most commercial signature platforms apply signatures in transit: outbound mail routes through the vendor's cloud, the signature is stamped on, the message continues. Deploy that in a hospital system and you've made a structural decision - a third party now processes your outbound mail, including whatever PHI ends up in it. Vendors in this category will sign BAAs and handle the responsibility professionally, but the obligations are still real: another business associate, another risk analysis entry, another breach-notification chain, another annual review - purchased alongside a signature tool.
There's an architecture that never raises the question. Atlas Ink by default applies signatures by provisioning, not stamping: it writes each user's own Outlook compose signature via the Exchange admin API, from a service running in your own Azure subscription. No message ever transits Atlas - so the mail-flow section of your risk analysis doesn't grow, and there's no in-transit processor to paper. The trade, stated honestly: pushed signatures cover mail composed with the mailbox signature. If policy requires an unremovable confidentiality footer on every message from every source, keep a plain Exchange transport-rule disclaimer for that layer - the two coexist without conflict, and most provider tenants run exactly this split.
Directory data is patient-adjacent data
The second flow to check: most SaaS signature tools sync directory attributes - names, credentials, departments, direct lines - into the vendor's environment to render templates. A provider directory isn't PHI, but it's sensitive operational data (and in behavioral-health and similar contexts, staff associations deserve care). Every copy outside your tenant is surface you now govern by contract instead of by access policy.
Atlas Ink reads Microsoft Entra ID in place, read-only, hydrating tokens at push time. Templates and assignments rest in a PostgreSQL database in your own subscription, encrypted with your Key Vault keys. No signature content leaves the tenant: Atlas receives an aggregate count of active users for metered billing via Stripe and, if you add clickable banners, the banner links and their click counts. If your compliance team wants the full flow-by-flow version, the data-residency walkthrough was written for them.
The clinical-directory problem is the real project
Here's the practical truth every health-system IT team knows: the hard part isn't the signature HTML, it's that the directory is wrong. Dr. Alvarez is still listed under the department she left in March; half the NPs' credentials are missing; the new surgery center's suite number lives in a spreadsheet.
Signature management done right forces the fix in the right place. Templates carry tokens - name, credentials, title, department, phone, office - that hydrate per user from Entra ID, so the remediation is a directory cleanup (which benefits every downstream system), not a thousand hand-edited signatures. When credentialing updates a provider's letters in Entra, the next push publishes them everywhere. Group-scoped assignment maps naturally onto clinical reality: a tenant default for staff, variants per service line or facility, individual exceptions where bylaws require them - most specific wins, deterministically.
And drift enforcement matters more in healthcare than almost anywhere: the daily reconcile quietly re-applies the assigned signature when a clinician's "improved" version drops their required credentials - and the deliberate per-user unmanaged switch handles the physician-executive whose office manages their correspondence.
What the review actually sees
Summing up the architecture in the terms your security and compliance reviewers will use:
- Not in your mail path - Atlas Ink isn't in your mail path and doesn't process message content, which can simplify your business-associate analysis - your counsel decides.
- No directory copy in a vendor cloud - Entra read in place, read-only.
- Data at rest inside your existing boundary - your subscription, your keys, your logs, covered by the Azure governance you already operate.
- No signature content leaves the tenant - Atlas receives the monthly active-user count for metered billing, at $1 per active user, always, billed via Stripe; if you add clickable banners, it also receives the banner links and their click counts.
For the wider platform story in a provider context - AVD for clinical workstations included - see the healthcare industry page. And if your shortlist includes the incumbent stampers, the honest comparisons are written: CodeTwo, Exclaimer, and the field guide. The question to put to each: which of these will my next risk analysis have to include - and which never enters it?